-
Publications
-
Meetings
-
Education
-
About
-
Resources
Advertisement
ADVERTISEMENT
Merakris announced the FDA has granted clearance to commence Part 2 of its Phase II clinical trial for an investigational new drug study of Dermacyte Liquid. The study will begin in late 2024 in up to 10 clinical sites.
Advertisement
Advertisement
Advertisement